BMC Geriatrics

, 10:A92 | Cite as

Cutaneus cancers in elderly Medical treatment of actinic keratosis and superficial coutaneus cancers: imiquimod

  • M N Dastoli
Open Access
Meeting abstract


Public Health Carcinoma Adverse Event Cell Carcinoma Medical Treatment 


The aim of this work is to evaluate the efficacy and safety of imiquimod 5% cream used in the treatment of certain non-melanoma skin cancers.

Materials and methods

We treated 30 subjects: 5 actinic keratosis, 3 cheratoacanthomas, 5 cutaneous horns, 5 superficial basal cell carcinomas, 12 nodular basal cell carcinomas according to the therapeutic pattern - five applications a week for 6-12 weeks -. The patients with nodular forms could not be treated with surgery for severe chronic deseases, age, or refusal.


Imiquimod 5% cream was effective and well tolerated both in actinic keratosis and in superficial and nodular basal cell carcinoma.


The treatment of certain non-melanoma coutaneous toumors with imiquimod 5% cream, has been effective, without collateral effects; erythema, edema, vesicles, crusts and erosions with itching or burning in the application area, have been the most frequent adverse events which however did not cause the suspension of therapy.

A diligent and continuative follow-up is necessary.

Copyright information

© Dastoli; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Authors and Affiliations

  • M N Dastoli
    • 1
  1. 1.ASP Cosenza, Corigliano CalabroItaly

Personalised recommendations